T2A2497 |
L-Glutamic acid
|
56-86-0
|
99.7%
|
|
L-Glutamic acid (Glutaminol) acts as an excitatory transmitter, shows a direct activating effect on the release of DA from dopaminergic terminals.
|
T0787 |
Butylhydroxyanisole
|
25013-16-5
|
99.7%
|
|
Butylhydroxyanisole (BHA) is an antioxidant consisting of a mixture of two isomeric organic compounds, 2-tert-butyl-4-hydroxyanisole and 3-tert-butyl-4-hydroxyan...
|
T60202 |
MMRi62
|
352693-80-2
|
99.7%
|
|
MMRi62 (7-[(2,3-dichlorophenyl)-(pyridin-2-ylamino)methyl]quinolin-8-ol), a ferroptosis inducer targeting MDM2-MDM4 (negative regulators of tumor suppressor p53)...
|
T77762 |
ROS-generating agent 1
|
2369030-41-9
|
99.67%
|
|
Ros-generating agent 1 has anticancer activity and generates ROS by covalently modifying Sec-498 residues of TrxR. ROS-generating agent 1 reduces intracellular T...
|
T6099 |
Setanaxib
|
1218942-37-0
|
99.66%
|
|
Setanaxib (GKT137831) is a potent, specific dual NADPH oxidase (NOX1/4) inhibitor.
|
T0214L |
Pioglitazone hydrochloride
|
112529-15-4
|
99.66%
|
|
Pioglitazone hydrochloride (AD 4833) is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic ac...
|
T2488 |
BAY 87-2243
|
1227158-85-1
|
99.65%
|
|
BAY 87-2243 is a potent and selective inhibitor of hypoxia-inducible factor-1 (HIF-1).
|
T3637 |
Pifithrin-β hydrobromide
|
511296-88-1
|
99.62%
|
|
Pifithrin-β hydrobromide (Cyclic PFT-α) is an inhibitor of p53; reversibly blocks p53-dependent transcriptional activation and apoptosis. Protects against neuron...
|
T0093L |
Sorafenib
|
284461-73-0
|
99.61%
|
|
Sorafenib (Bay 43-9006) is a multikinase inhibitor that inhibits Raf-1, B-Raf, VEGFR2, VEGFR3, VEGFR4, PDGFRβ, FLT3, c-Kit, and others (IC50=6/22/90/15/20/20/57/...
|
T1564 |
Cisplatin
|
15663-27-1
|
99.6%
|
|
Cisplatin (CDDP) is a DNA cross-linking agent. Cisplatin has antitumor activity and inhibits DNA synthesis by forming DNA adducts in cancer cells. Cisplatin also...
|
T1765 |
Erastin
|
571203-78-6
|
99.6%
|
|
Erastin is an iron death activator that acts on the mitochondrial VDAC in a ROS- and iron-dependent manner. Erastin has anti-tumor activity and acts selectively ...
|
T5515 |
Hemin
|
16009-13-5
|
99.59%
|
|
Hemin (Hemin chloride) is a chlorinated iron-containing porphyrin, a heme oxygenase (HO)-1 inducer. Hemin has therapeutic activity in porphyrias by reducing heme...
|
T1207 |
Lovastatin
|
75330-75-5
|
99.59%
|
|
Lovastatin (MK-803) is an HMG-CoA Reductase Inhibitor, used for lowering cholesterol.
|
T3109 |
SP600125
|
129-56-6
|
99.58%
|
|
SP600125 (JNK Inhibitor II) is a JNK inhibitor that inhibits JNK1, JNK2, and JNK3 (IC50=40/40/90 nM) with oral potency, reversibility, and ATP-competitive proper...
|
T4414 |
Eprenetapopt
|
5291-32-7
|
99.57%
|
|
Eprenetapopt (PRIMA-1Met) restores wild-type conformation and function to mutant p53, and triggers apoptosis in tumor cells. PRIMA-1MET also targets the selenopr...
|
T0214 |
Pioglitazone
|
111025-46-8
|
99.57%
|
|
Pioglitazone (U 72107) is an insulin sensitizing agent and thiazolidinedione that is indicated for the treatment of type 2 diabetes. Pioglitazone has been linked...
|
T0477 |
Zileuton
|
111406-87-2
|
99.56%
|
|
Zileuton (A 64077) is a synthetic derivative of hydroxyurea with antiasthmatic properties. The leukotriene inhibitor zileuton blocks 5-lipoxygenase, which cataly...
|
T6500 |
Ferrostatin-1
|
347174-05-4
|
99.51%
|
|
Ferrostatin-1 (Fer-1) is a potent and selective inhibitor of iron death. Ferrostatin-1 potently inhibits Erastin-induced iron death in HT-1080 cells with an EC50...
|
T1487 |
Fluvastatin sodium
|
93957-55-2
|
99.46%
|
|
Fluvastatin sodium (Fluvastatin sodium salt), a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), is a commonly used cholesterol lower...
|
T2376 |
Liproxstatin-1
|
950455-15-9
|
99.44%
|
|
Liproxstatin-1 is a potent and selective inhibitor of iron death (IC50=22 nM). Liproxstatin-1 protects cells from iron death induced by iron death inducers (e.g....
|